On June 16, 2021, Greenrose issued
an updated presentation (the “Investor Presentation”) included as Exhibit 99.1 hereto and incorporated by reference
into this Item 8.01. Greenrose provides the Investor Presentation as an update to the Investor Presentation filed by Greenrose on its
Current Report on Form 8-K filed March 18, 2021 (the “March 18, 2021 Presentation”).
The Investor Presentation filed
herewith and the financial information and projections reflected therein replace and supersede in all respects the March 18, 2021 Presentation.
The March 18, 2021 Presentation should no longer be relied upon by investors, potential investors or other third parties.
The Investor Presentation includes
financial information not prepared in accordance with generally accepted accounting principles.
The information contained in the
Investor Presentation is summary information that is intended to be considered in the context of Greenrose’s SEC filings and other
public announcements that Greenrose may make, by press release or otherwise, from time to time. Greenrose undertakes no duty or obligation
to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes
is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through
other public disclosure.
By filing this Current Report
on Form 8-K and furnishing the information contained herein, Greenrose makes no admission as to the materiality of any information in
this report that is required to be disclosed solely by reason of Regulation FD.
Forward Looking Statements
This Current Report on Form 8-K
includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions
under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words
such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,”
“intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,”
“seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate
future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited
to, statements regarding estimates and forecasts of revenue and other financial and performance metrics and projections of market opportunity
and expectations, Greenrose’s ability to enter into definitive agreements or consummate a transaction with any of Shango Holdings Inc.,
or Shango, Futureworks LLC (d/b/a The Health Center), or Futureworks, Theraplant, LLC, or Theraplant, or True Harvest, LLC,
or True Harvest to obtain the financing necessary consummate its previously announced proposed transactions; and the expected timing of
completion of the Proposed Transactions. These statements are based on various assumptions and on the current expectations of Greenrose’s
and any of Shango, Theraplant, True Harvest, or Futureworks’ management and are not predictions of actual performance. These forward-looking
statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as,
a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult
or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Greenrose and
any of Shango, Theraplant, True Harvest, or Futureworks. These forward-looking statements are subject to a number of risks and uncertainties,
including general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the inability
of the parties to enter into definitive agreements or successfully or timely consummate the Proposed Transactions or to satisfy the other
conditions to the closing of the Proposed Transactions, including the risk that any required regulatory approvals are not obtained, are
delayed or are subject to unanticipated conditions that could adversely affect the combined company; the risk that the approval of the
Greenrose Stockholders for the Proposed Transactions is not obtained; failure to realize the anticipated benefits of the Proposed Transactions,
including as a result of a delay in consummating any of the Proposed Transactions or difficulty in, or costs associated with, integrating
the businesses of Greenrose and any of Shango, Theraplant, True Harvest, or Futureworks; the amount of redemption requests made by the
Greenrose Stockholders; the occurrence of events that may give rise to a right of Greenrose and any of Shango, Theraplant, True Harvest,
or Futureworks to terminate the respective Merger Agreements or Asset Purchase Agreements, as applicable; risks related to the rollout
of Greenrose’ business and the timing of expected business milestones; the effects of competition on Greenrose’s business;
and those factors discussed in Greenrose’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 under the heading
“Risk Factors,” and other documents of Greenrose filed, or to be filed, with the SEC. If the risks materialize or assumptions
prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional
risks that neither Greenrose nor any of Shango, Theraplant, True Harvest, or Futureworks presently know or that Greenrose and any of Shango,
Theraplant, True Harvest, or Futureworks currently believe are immaterial that could also cause actual results to differ from those contained
in the forward-looking statements. In addition, forward-looking statements reflect Greenrose’s and each of Shango, Theraplant, True
Harvest, or Futureworks’ expectations, plans or forecasts of future events and views as of the date of this Current Report on Form
8-K. Greenrose and each of Shango, Theraplant, True Harvest, and Futureworks anticipate that subsequent events and developments will cause
their assessments to change. However, while Greenrose and any of Shango, Theraplant, True Harvest, or Futureworks may elect to update
these forward-looking statements at some point in the future, Greenrose and each of Shango, Theraplant, True Harvest, and Futureworks
specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Greenrose’s
or any of any of Shango, Theraplant, True Harvest, or Futureworks’ assessments as of any date subsequent to the date of this Current
Report on Form 8-K. Accordingly, undue reliance should not be placed upon the forward-looking statements.